lomefloxacin has been researched along with Gram-Negative Bacterial Infections in 5 studies
lomefloxacin: structure given in first source
lomefloxacin : A fluoroquinolone antibiotic, used (generally as the hydrochloride salt) to treat bacterial infections including bronchitis and urinary tract infections. It is also used to prevent urinary tract infections prior to surgery.
Gram-Negative Bacterial Infections: Infections caused by bacteria that show up as pink (negative) when treated by the gram-staining method.
Excerpt | Relevance | Reference |
---|---|---|
"Nine centers in Italy participated in a worldwide, multicenter study comparing the effectiveness and safety of lomefloxacin and amoxicillin in patients with acute exacerbations of chronic bronchitis caused mainly by gram-negative pathogens." | 9.07 | Lomefloxacin versus amoxicillin in the treatment of acute exacerbations of chronic bronchitis: an Italian multicenter study. ( Albera, C; Grassi, C; Pozzi, E, 1992) |
"Lomefloxacin has been shown to produce high and sustained concentrations in serum and bronchial mucosa after once-daily administration." | 6.67 | A double-blind study of two dosage regimens of lomefloxacin in bacteriologically proven exacerbations of chronic bronchitis of gram-negative etiology. ( Kemper, P; Köhler, D, 1992) |
"Nine centers in Italy participated in a worldwide, multicenter study comparing the effectiveness and safety of lomefloxacin and amoxicillin in patients with acute exacerbations of chronic bronchitis caused mainly by gram-negative pathogens." | 5.07 | Lomefloxacin versus amoxicillin in the treatment of acute exacerbations of chronic bronchitis: an Italian multicenter study. ( Albera, C; Grassi, C; Pozzi, E, 1992) |
"Lomefloxacin has been shown to produce high and sustained concentrations in serum and bronchial mucosa after once-daily administration." | 2.67 | A double-blind study of two dosage regimens of lomefloxacin in bacteriologically proven exacerbations of chronic bronchitis of gram-negative etiology. ( Kemper, P; Köhler, D, 1992) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (80.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ko, WC | 1 |
Chiang, SR | 1 |
Lee, HC | 1 |
Tang, HJ | 1 |
Wang, YY | 1 |
Chuang, YC | 1 |
Belliveau, P | 1 |
Nightingale, CH | 1 |
Quintiliani, R | 1 |
Crowe, H | 1 |
Gousee, G | 1 |
Spivey, IM | 1 |
Grassi, C | 1 |
Albera, C | 1 |
Pozzi, E | 1 |
Kemper, P | 1 |
Köhler, D | 1 |
1 review available for lomefloxacin and Gram-Negative Bacterial Infections
Article | Year |
---|---|
Oral ciprofloxacin, ofloxacin, and lomefloxacin as alternatives to intravenous antimicrobial therapy.
Topics: Administration, Oral; Anti-Bacterial Agents; Ciprofloxacin; Drug Costs; Drug Tolerance; Female; Fluo | 1993 |
2 trials available for lomefloxacin and Gram-Negative Bacterial Infections
Article | Year |
---|---|
Lomefloxacin versus amoxicillin in the treatment of acute exacerbations of chronic bronchitis: an Italian multicenter study.
Topics: Acute Disease; Aged; Amoxicillin; Anti-Infective Agents; Bronchitis; Chi-Square Distribution; Chroni | 1992 |
A double-blind study of two dosage regimens of lomefloxacin in bacteriologically proven exacerbations of chronic bronchitis of gram-negative etiology.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bronchitis; Chi-Square Distribution; Chronic | 1992 |
2 other studies available for lomefloxacin and Gram-Negative Bacterial Infections
Article | Year |
---|---|
In vitro and in vivo activities of fluoroquinolones against Aeromonas hydrophila.
Topics: Aeromonas hydrophila; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Cefotaxi | 2003 |
Criteria for use of ofloxacin and lomefloxacin in adult inpatients and outpatients.
Topics: Adult; Anti-Infective Agents; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Infectio | 1993 |